IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYANASDAQ

IDEAYA Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yujiro S. Hata, with a market cap of $2.7B.

Market Cap$2.7B
Employees124.0
CEOYujiro S. Hata
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. FAQ

Common questions about IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $5.9M.

IDEAYA Biosciences, Inc. has approximately 124 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

IDEAYA Biosciences, Inc. (IDYA) Q1 2026 Earnings - OpenCapital